Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-026891
Date:2022-04-30
Issuer: NURIX THERAPEUTICS, INC. (NRIX)
Original Submission Date:

Reporting Person:

WOLFF STEFANI
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205 SAN FRANCISCO, CA 94158

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-04-30 M 962 a $0.00 962 direct
COMMON STOCK 2022-05-02 S 330 d $11.75 632 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2022-04-30 deemed execution date M 962 (d) common stock 962 $0.00 14,430 direct
Footnotes
IDfootnote
f1 the sales reported on this form 4 represent shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units ("rsus"). these sales are mandated by the issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the reporting person.
f2 each rsu represents a contingent right to receive one share of the issuer's common stock.
f3 the rsus will vest in substantially equal increments quarterly over four years, with the first quarterly increment vesting on april 30, 2022, subject to the reporting person's provision of services to the issuer on each vesting date. shares of the issuer's common stock will be delivered to the reporting person following vesting.
f4 rsus do not expire; they either vest or are canceled prior to the vest date.
WhaleWisdom Logo

Elevate your investments